These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30674578)

  • 21. Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients.
    Van Deun A; Aung KJ; Hossain A; de Rijk P; Gumusboga M; Rigouts L; de Jong BC
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):185-90. PubMed ID: 25574917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparing performance of "TB-BIOCHIP", "Xpert MTB/RIF" and "genotype MTBDRplus" assays for fast identification of mutations in the Mycobacterium tuberculosis complex in sputum from TB patients].
    Nosova EIu; Krasnova MA; Galkina KIu; Makarova MV; Litvinov VI; Moroz AM
    Mol Biol (Mosk); 2013; 47(2):267-74. PubMed ID: 23808160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Isoniazid and Rifampin Resistance in Mycobacterium tuberculosis Clinical Isolates from Sputum Samples by High-Resolution Melting Analysis.
    Parsa S; Yaghoubi A; Izadi N; Sabet F; Nik LB; Derakhshan M; Rezaee SA; Meshkat Z; Hoseini SJ; Jmehdar SA; Kiani F; Samiei A; Soleimanpour S
    Curr Microbiol; 2022 Jul; 79(9):257. PubMed ID: 35852629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The performance of Xpert MTB/RIF and MTBDRplus within a Programmatic setting at TB Laboratory in Rio de Janeiro, Brazil.
    Malaquias TDSS; Ribeiro EP; Dutra TCP; Ricardo M; Salvato R; Bhering M; Bartholomeu DC; Dalla-Costa ER; Viveiros M; Silva ECD; Kritski A
    Rev Soc Bras Med Trop; 2024; 57():e004162024. PubMed ID: 39292021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
    Bisimwa BC; Nachega JB; Warren RM; Theron G; Metcalfe JZ; Shah M; Diacon AH; Sam-Agudu NA; Yotebieng M; Bulabula ANH; Katoto PDMC; Chirambiza JP; Nyota R; Birembano FM; Musafiri EM; Byadunia S; Bahizire E; Kaswa MK; Callens S; Kashongwe ZM
    Clin Infect Dis; 2021 Jul; 73(2):e362-e370. PubMed ID: 32590841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automatic Identification of Individual
    Cao Y; Parmar H; Simmons AM; Kale D; Tong K; Lieu D; Persing D; Kwiatkowski R; Alland D; Chakravorty S
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31533985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of Gene Xpert Mycobacterium tuberculosis DNA and resistance to rifampicin assay in the rapid detection of tuberculosis in children].
    Zhang AM; Li F; Liu XH; Xia L; Lu SH
    Zhonghua Er Ke Za Zhi; 2016 May; 54(5):370-4. PubMed ID: 27143080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis.
    Jamieson FB; Guthrie JL; Neemuchwala A; Lastovetska O; Melano RG; Mehaffy C
    J Clin Microbiol; 2014 Jun; 52(6):2157-62. PubMed ID: 24740074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the analytical performance of the Xpert MTB/RIF assay.
    Blakemore R; Story E; Helb D; Kop J; Banada P; Owens MR; Chakravorty S; Jones M; Alland D
    J Clin Microbiol; 2010 Jul; 48(7):2495-501. PubMed ID: 20504986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Tan Y; Hu Z; Zhao Y; Cai X; Luo C; Zou C; Liu X
    J Clin Microbiol; 2012 Jan; 50(1):81-5. PubMed ID: 22075601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Application of Xpert Mycobacterium tuberculosis/Rifampicin, Quantitative Polymerase Chain Reaction and High Resolution Melting Curve in the Diagnosis of Superficial Lymph Node TB.
    Han Y; Xiao N; Huang S; Qin M; Che N; Liu Z
    Curr Pharm Biotechnol; 2019; 20(12):1044-1054. PubMed ID: 31333119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid molecular detection of tuberculosis and rifampin resistance.
    Boehme CC; Nabeta P; Hillemann D; Nicol MP; Shenai S; Krapp F; Allen J; Tahirli R; Blakemore R; Rustomjee R; Milovic A; Jones M; O'Brien SM; Persing DH; Ruesch-Gerdes S; Gotuzzo E; Rodrigues C; Alland D; Perkins MD
    N Engl J Med; 2010 Sep; 363(11):1005-15. PubMed ID: 20825313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
    Ciftçi IH; Aslan MH; Aşık G
    Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the
    Guo Y; Cao X; Yang J; Wu X; Liu Y; Wan B; Hu L; Wang H; Yu F
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33507146
    [No Abstract]   [Full Text] [Related]  

  • 39. Discordance between Xpert MTB/RIF assay and Bactec MGIT 960 Culture System for detection of rifampin-resistant Mycobacterium tuberculosis isolates in a country with a low tuberculosis (TB) incidence.
    Mokaddas E; Ahmad S; Eldeen HS; Al-Mutairi N
    J Clin Microbiol; 2015 Apr; 53(4):1351-4. PubMed ID: 25609730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis.
    Nhu NT; Heemskerk D; Thu do DA; Chau TT; Mai NT; Nghia HD; Loc PP; Ha DT; Merson L; Thinh TT; Day J; Chau Nv; Wolbers M; Farrar J; Caws M
    J Clin Microbiol; 2014 Jan; 52(1):226-33. PubMed ID: 24197880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.